Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
72.14
-0.16 (-0.22%)
Nov 13, 2026, 4:00 PM EST - Market closed
Globus Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,140 | 2,939 | 2,519 | 1,568 | 1,023 | 958.1 |
Revenue Growth | 13.35% | 16.65% | 60.62% | 53.34% | 6.76% | 21.43% |
Gross Profit Gross Profit Growth | 2,177 | 2,001 | 1,699 | 1,092 | 760.01 | 718.88 |
Operating Income Operating Income Growth | 746.08 | 600.27 | 441.03 | 273.51 | 237.15 | 194.86 |
Net Income Net Income Growth | 557.64 | 537.87 | 102.98 | 122.87 | 190.17 | 149.19 |
Earnings Per Share EPS Growth | 4.06 | 3.92 | 0.75 | 1.07 | 1.85 | 1.44 |
EPS Growth | 31.85% | 422.67% | -29.91% | -42.16% | 28.47% | 42.57% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Musculoskeletal Solutions Musculoskeletal Solutions Growth | 2,996 | 2,798 | 2,365 | 1,448 | 926.7 | 876.78 |
Enabling Technologies Enabling Technologies Growth | 143.43 | 141.01 | 154 | 120.22 | 96.14 | 81.32 |
Revenue (Total) Revenue (Total) Growth | 3,140 | 2,939 | 2,519 | 1,568 | 1,023 | 958.1 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 871.17 | 629.06 | 956.19 | 593.22 | 941.91 | 1,006 |
Total Debt Total Debt Growth | 108.19 | 119.44 | 537.72 | 521.22 | 6.01 | - |
Net Cash (Debt) Net Cash Growth | 762.99 | 509.62 | 418.47 | 72 | 935.9 | 1,006 |
Net Cash Growth | 165.76% | 21.78% | 481.20% | -92.31% | -6.96% | 28.89% |
Net Cash Per Share Net Cash Per Share Growth | 5.57 | 3.72 | 3.04 | 0.63 | 9.12 | 9.71 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 925.92 | 753.45 | 520.64 | 243.5 | 178.47 | 276.27 |
Capital Expenditures CapEx Growth | -159.37 | -164.68 | -115.43 | -78.27 | -74.05 | -56.9 |
Free Cash Flow Free Cash Flow Growth | 766.55 | 588.77 | 405.21 | 165.23 | 104.42 | 219.38 |
Free Cash Flow Growth | 32.25% | 45.30% | 145.25% | 58.23% | -52.40% | 62.34% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 69.33% | 68.07% | 67.46% | 69.62% | 74.30% | 75.03% |
Operating Margin | 23.76% | 20.42% | 17.51% | 17.44% | 23.18% | 20.34% |
Pretax Margin | 22.28% | 20.59% | 4.79% | 10.54% | 23.76% | 18.83% |
Profit Margin | 17.76% | 18.30% | 4.09% | 7.83% | 18.59% | 15.57% |
FCF Margin | 24.41% | 20.03% | 16.08% | 10.53% | 10.21% | 22.90% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.77 | 21.73 | 109.36 | 59.76 | 38.99 | 49.11 |
Forward PE | 13.97 | 21.59 | 25.54 | 20.76 | 32.74 | 33.48 |
P/FCF Ratio | 12.47 | 19.85 | 27.79 | 44.44 | 71.01 | 33.40 |
PS Ratio | 3.04 | 3.98 | 4.47 | 4.68 | 7.25 | 7.65 |